49. Ridolo E, Martignago I, Riario-Sforza GG, Incorvaia C. Allergen immunotherapy in atopic dermatitis. Expert Rev Clin Immunol. 2018;14:61–68.
50. Slavyanakaya T, Derkach VV, Sepiashvili RI. Debates in allergy medicine: specific immunotherapy efficiency in children with atopic dermatitis. World Allergy Organ J. 2016; 9:15.
51. Tam H, Calderon MA, Manikam L. Specific allergen immunotherapy for the treatment of atopic eczema. Cochrane Database Syst Rev. 2016 Feb 12; 2:CD008774.
52. C Pitsios et.al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015 Aug; 70(8):897–909.
53. Allam JP et al. Phl p 5 resorption in human oral mucosa leads to dose-dependent and timedependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol. 2010;126(3):638–645.
